Literature DB >> 11420719

Glucocorticoid receptor-mediated chromatin remodeling in vivo.

B J Deroo1, T K Archer.   

Abstract

The compaction of DNA into chromatin provides an additional level of gene regulation in eukaryotes that may not be available to prokaryotes. When packaged as chromatin, most promoters are transcriptionally repressed, and transcription factors have reduced access to their binding sites. The glucocorticoid receptor (GR) is a ligand-activated transcription factor that regulates the activity of genes involved in many physiological processes. To regulate eukaryotic genes, the GR binds to target sites within promoter regions of genes assembled as chromatin. This interaction alters the nucleosomal architecture to allow binding of other transcription factors, and formation of the preinitiation complex. The mouse mammary tumor virus (MMTV) promoter has been used extensively as a model to explore the processes by which the GR remodels chromatin and activates transcription. Significant progress has been made in our understanding of the mechanisms used by the GR to modify chromatin structure, and the limits placed on the GR by post-translational modifications of histones. We will describe recent developments in the processes used by the GR to activate transcription in vivo via chromatin remodeling complexes, histone H1 phosphorylation, and recruitment of diverse coactivators.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11420719     DOI: 10.1038/sj.onc.1204328

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  26 in total

Review 1.  Emerging roles of the 26S proteasome in nuclear hormone receptor-regulated transcription.

Authors:  Brian R Keppler; Trevor K Archer; H Karimi Kinyamu
Journal:  Biochim Biophys Acta       Date:  2010-08-20

2.  Murine endogenous retroviruses and their transcriptional potentials.

Authors:  Jerry Boonyaratanakornkit; Alex Chew; Dewey D Y Ryu; David G Greenhalgh; Kiho Cho
Journal:  Mamm Genome       Date:  2004-11       Impact factor: 2.957

3.  Dexamethasone-induced up-regulation of the human norepinephrine transporter involves the glucocorticoid receptor and increased binding of C/EBP-β to the proximal promoter of norepinephrine transporter.

Authors:  Qinqin Zha; Yan Wang; Yan Fan; Meng-Yang Zhu
Journal:  J Neurochem       Date:  2011-09-28       Impact factor: 5.372

Review 4.  Chromatin remodeling during glucocorticoid receptor regulated transactivation.

Authors:  Heather A King; Kevin W Trotter; Trevor K Archer
Journal:  Biochim Biophys Acta       Date:  2012-03-06

5.  Dexamethasone induces transcriptional activation of Bcl-xL gene and inhibits cardiac injury by myocardial ischemia.

Authors:  Beibei Xu; Joshua Strom; Qin M Chen
Journal:  Eur J Pharmacol       Date:  2011-06-25       Impact factor: 4.432

6.  Assaying chromatin structure and remodeling by restriction enzyme accessibility.

Authors:  Kevin W Trotter; Trevor K Archer
Journal:  Methods Mol Biol       Date:  2012

Review 7.  Complex genomic interactions in the dynamic regulation of transcription by the glucocorticoid receptor.

Authors:  Tina B Miranda; Stephanie A Morris; Gordon L Hager
Journal:  Mol Cell Endocrinol       Date:  2013-03-14       Impact factor: 4.102

Review 8.  Chromatin-modifying enzymes as therapeutic targets--Part 2.

Authors:  Brian R Keppler; Trevor K Archer
Journal:  Expert Opin Ther Targets       Date:  2008-11       Impact factor: 6.902

9.  Chronic social defeat up-regulates expression of the serotonin transporter in rat dorsal raphe nucleus and projection regions in a glucocorticoid-dependent manner.

Authors:  Jia Zhang; Yan Fan; Ying Li; Hobart Zhu; Liang Wang; Meng-Yang Zhu
Journal:  J Neurochem       Date:  2012-11-07       Impact factor: 5.372

10.  SWI/SNF deficiency results in aberrant chromatin organization, mitotic failure, and diminished proliferative capacity.

Authors:  Ryan J Bourgo; Hasan Siddiqui; Sejal Fox; David Solomon; Courtney G Sansam; Moshe Yaniv; Christian Muchardt; Daniel Metzger; Pierre Chambon; Charles W M Roberts; Erik S Knudsen
Journal:  Mol Biol Cell       Date:  2009-05-20       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.